Well, it looks like Diabetes Insipidus is on the way out, at least from the naming point of view. After the work done in Basel (Universitätsspital Basel), recently published in The Lancet, an international consensus group proposed a name change from Diabetes Insipidus to Arginine Vasopressin Deficiency or AVP-D, or Arginine Vasopressin Resistance or AVP-R, depending on the type.
Amplifying great work: Great patient participation reported in Diabetes Insipidus Survey
Last year, Got Diabetes Insipidus group director Pat Gildroy was asked to be the patient representative for the development and distribution of the DImond Patient Survey. Pat reached out to PWN for help in generating responses
Diabetes Insipidus: a common condition for Histiocytosis and Pituitary conditions
Today’s podcast focuses on an opportunity to learn about a group of rare diseases that share a common condition with pituitary disease. Histiocytosis or histiocytic disorders are a group of rare diseases that occur when there is an overproduction of white blood cells known as histiocytes that can lead to organ damage and tumor formation. DI impacts almost 50% of Histiocytosis patients and 35% of pituitary patients.
Live talk, session 2 – April 14, 2022: Diabetes Insipidus and a discussion about endocrine tests
Dr. Lewis Blevins discusses the normal ranges of endocrine lab tests and shares examples from his pituitary practice. Also, our guest this week, Pat Gildroy, who manages the Diabetes Insipidus Facebook group, Got DI, joins us for a fascinating discussion about this condition.
Help the medical field learn more about Central Diabetes Insipidus
Help us increase the medical field’s knowledge of CDI by participating in this short five-minute anonymous survey. An international team of researchers will collect the patient data to help physicians and patients understand how to manage DI
Critical insights on Diabetes Insipidus
DI: 2 cases
In this informative podcast on Diabetes Insipidus, Dr. Blevins discusses two recent cases.
How does vasopressin work?
From Lewis S. Blevins, Jr. MD – Vasopressin acts on the kidney to resorb water from the urine to restore plasma osmolarity to normal to prevent dehydration. Simple enough. Right? Hold on a minute! Our
Thirsty? For water? How about knowledge?
From Lewis S. Blevins, Jr. MD – Ever wondered why your sense of thirst and the control of your diabetes insipidus reflected by the degree of polyuria might seem disconnected? Well, it’s because they are!
Diabetes Insipidus: Our survey report is in!
From Lewis S Blevins, Jr MD – One hundred ninety-eight persons completed our survey on diabetes insipidus. Approximately two-thirds of respondents reside in the United States whereas 14% live in Great Britain, 7% live in
Diabetes Insipidus Survey
This is a questionnaire/survey on Diabetes Insipidus. Thank you for participating. Your responses and insights will be gleaned to write an article for Pituitary World News. Click here to start the Diabetes Insipidus Survey And stay tuned
From Lewis S Blevins Jr., MD – desamino d-arginine vasopressin…..in case you ever wondered. DDAVP therapy has evolved somewhat over the past quarter of a century. When I started my training one of the common
Diabetes insipidus: Polyuria.
Polyuria is defined as the passage of excessive quantities of urine. Pollakauria is defined as urinary frequency; in other words, more trips to the bathroom regardless of urine volume. Polyuria is arbitrarily defined as the